Pages that link to "Q74213485"

The following pages link to Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin (Q74213485):

Displaying 42 items.

• Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma (Q24670255) (← links)
• Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes (Q26801785) (← links)
• Jumping translocation in acute monocytic leukemia (M5b) with alternative breakpoint sites in the long arm of donor chromosome 3. (Q33385496) (← links)
• NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas (Q33396947) (← links)
• The Mi-2/NuRD complex associates with pericentromeric heterochromatin during S phase in rapidly proliferating lymphoid cells (Q33601155) (← links)
• Genome architecture catalyzes nonrecurrent chromosomal rearrangements (Q33904646) (← links)
• CKS1B nuclear expression is inversely correlated with p27Kip1 expression and is predictive of an adverse survival in patients with multiple myeloma (Q34095647) (← links)
• International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. (Q34241661) (← links)
• The molecular classification of multiple myeloma (Q34530992) (← links)
• Genomic complexity of multiple myeloma and its clinical implications (Q34537571) (← links)
• The relationship between spontaneous telomere loss and chromosome instability in a human tumor cell line. (Q34786093) (← links)
• Recurrent genomic instability of chromosome 1q in neural derivatives of human embryonic stem cells (Q35698880) (← links)
• Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma (Q35724013) (← links)
• Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma (Q35746961) (← links)
• Jumping translocations, a novel finding in chronic lymphocytic leukaemia (Q35812073) (← links)
• CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms (Q35828815) (← links)
• Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment (Q35834538) (← links)
• Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transpla (Q35848978) (← links)
• 1q12 chromosome translocations form aberrant heterochromatic foci associated with changes in nuclear architecture and gene expression in B cell lymphoma (Q36039261) (← links)
• ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation (Q36725211) (← links)
• Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor Survival (Q36816733) (← links)
• Evidence for a novel mechanism for gene amplification in multiple myeloma: 1q12 pericentromeric heterochromatin mediates breakage-fusion-bridge cycles of a 1q12 approximately 23 amplicon (Q37082758) (← links)
• Abnormalities in Chromosomes 1q and 13 Independently Correlate With Factors of Poor Prognosis in Multiple Myeloma (Q37231523) (← links)
• Isochromosome Yp and jumping translocation of Yq resulting in five cell lines in an infertile male: a case report and review of the literature (Q37358995) (← links)
• A role for epigenetics in the formation of chromosome translocations in acute leukemia (Q37441132) (← links)
• Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease (Q37709342) (← links)
• Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma (Q39991460) (← links)
• Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma. (Q40492260) (← links)
• Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis (Q42792442) (← links)
• A case of salivary-type amylase-producing multiple myeloma presenting as mediastinal plasmacytoma and myelomatous pleural effusion (Q42969990) (← links)
• Unbalanced jumping translocation involving 3q in myeloproliferative disease (Q46569789) (← links)
• Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review. (Q47095937) (← links)
• Evolutionary biology of high-risk multiple myeloma (Q47913337) (← links)
• Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential Giemsa banding and spectral karyotyping (Q57791122) (← links)
• The unbalanced chromosomal translocation der(15)t(1;15)(q21;p13) in multiple myeloma (Q81205766) (← links)
• Jumping translocations of chromosome 1q occurring by a multi-stage process in an acute myeloid leukemia progressed from myelodysplastic syndrome with a TET2 mutation (Q91895704) (← links)
• Remodeling and destabilization of chromosome 1 pericentromeric heterochromatin by SSX proteins (Q92203092) (← links)
• An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome (Q92534246) (← links)
• Interaction between Polycomb and SSX Proteins in Pericentromeric Heterochromatin Function and Its Implication in Cancer (Q92810141) (← links)
• The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation (Q92916885) (← links)
• Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions (Q94545332) (← links)
• Drug Targeting of Genomic Instability in Multiple Myeloma (Q94561677) (← links)